Drug Discovery Opinion

Roles have been suggested for brain-derived neurotrophic factor (BDNF) – which helps to support neurons and also stimulates and controls neurogenesis – in preventing or treating degenerative diseases such amyotrophic lateral sclerosis, Parkinson’s disease, and Alzheimer’s disease. The use of BDNF itself in therapy is limited by a poor pharmokinetic profile including rapid metabolism and poor CNS penetration. BDNF elicits at least some of its effects through binding to the high affinity tyrosine kinase receptor B, TrkB, and investigators at Emory University School of Medicine have now identified a small, high-affinity molecule that can also activate signalling through TrkB.

7,8-Dihydroxyflavone was shown to protect wild-type, but not TrkB-deficient, neurons from apoptosis. Following intraperitoneal administration, the compound was also found to activate TrkB in the brain and to be protective in animal models of seizure, stroke and Parkinson’s disease. The compound was also found to have low toxicity on chronic dosing. Although favonoids such as 7,8-dihydroxyflavone occur in a wide range of foodstuffs, levels obtained from a normal diet are believed to be insufficient for a sustained effect.

The study is published in the online early edition of PNAS.

Related posts:

1. Amitriptyline Directly Stimulates Trk Receptors Neurotrophins – a family of proteins essential for the development, survival and function of neurons – exert their actions through...
2. How Small Molecule Restores Aldehyde Dehydrogenase Function The lower alcohol tolerance of some Asian groups compared with people of European descent is caused, in part, by a...
3. Role for CDK5 in Adult Neurogenesis For many years, it was been believed that we were born with all the brain cells we would ever have,...
4. New Brain Delivery Strategy for Parkinson’s Disease The blood-brain barrier (BBB) fulfills an essential role by restricting the entry of potentially neurotoxic chemicals into brain tissue. The...
5. Phosphorylation Modulates α-Synuclein Neurotoxicity α-Synuclein, expressed primarily in neural tissue, is normally an unstructured, soluble, protein. Under some circumstances, however, it has the ability...

Related posts brought to you by Yet Another Related Posts Plugin.

 Email This Post

This entry was posted on Thursday, January 28th, 2010 at 8:47 am and is filed under News. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.